Gene · 7939
LAP: Laryngeal adductor paralysis
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. LAP: Laryngeal adductor paralysis. Genes, record 7939. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7939
On this page
Gene
- Symbol
- LAP
- Name
- Laryngeal adductor paralysis
- NCBI Gene ID
- 7939
- Type
- unknown
Source NCBI Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,570
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LAP papers | Newest fiscal year |
|---|---|---|---|
| P30CA047904 | Cancer Center Support Grant | 9 | 2025 |
| P20GM103446 | Delaware INBRE | 7 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 7 | 2025 |
| P20GM103432 | Wyoming IDeA Networks for Biomedical Research Excellence Phase 4 | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 5 | 2025 |
| R01AR056624 | Dynamic Acellular Materials for Repairing Dense Connective Tissues | 5 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 4 | 2025 |
| P30CA142543 | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | 4 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 4 | 2025 |
1 to 10 of 1,570Source NIH's project files
See all 1,570 nih grantsPapers2,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unsupervised proteomic stratification of people living with HIV reveals inflammatory biotypes beyond conventional clinical classifications. | Front Immunol | 2026 | 42787960 | PubTator, text mining | PubMed |
| The transcription factor C/EBPβ promotes hyperglycemia-elicited glycolysis and liver cancer progression. | Nat Commun | 2026 | 42722647 | PubTator, text mining | PubMed |
| Biomarkers in Obesity-Related Metabolic Syndrome: Relationships Between LDL Subfractions, Lipid Profile, and Cardiometabolic Risk in a Slovak Population. | Metabolites | 2026 | 42646303 | PubTator, text mining | PubMed |
| Hierarchical drug-releasing nanocomposite hydrogel for postoperative synergistic chemo-photothermal therapy of uveal melanoma. | Mater Today Bio | 2026 | 42602874 | PubTator, text mining | PubMed |
| Genetic analysis of inflammatory proteins following BCG vaccination in Danish children. | Biomed Pharmacother | 2026 | 42594746 | PubTator, text mining | PubMed |
| Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance. | Drug Resist Updat | 2026 | 42556029 | PubTator, text mining | PubMed |
| [Study on Huanglian Jiedu Decoction improving ox-LDL-induced LC3-related phagocytosis dysfunction in RAW264.7 macrophages by activating ERK5]. | Zhongguo Zhong Yao Za Zhi | 2026 | 42543371 | PubTator, text mining | PubMed |
| Immune parameters correlate with fibrinolysis and predict efficacy of ultrasound-assisted catheter-directed thrombolysis in acute pulmonary embolism. | J Thromb Haemost | 2026 | 42480856 | PubTator, text mining | PubMed |
| Pemafibrate Improves Cholestatic Markers Regardless of the Presence of Primary Biliary Cholangitis. | Hepatol Res | 2026 | 42458967 | PubTator, text mining | PubMed |
| Machine learning-based analysis of oral rinse samples to identify candidate proteomic signatures for severe periodontitis: a pilot study. | Sci Rep | 2026 | 42448777 | PubTator, text mining | PubMed |
1 to 10 of 2,932
See all 2,932 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7939
GET https://conductscience.org/api/genes/v1/7939/grants?page=2